Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Jul 28, 2017 11:55PM

Jul 29, 2017 12:03AM

Jul 29, 2017 12:17AM

masila

Jul 29, 2017 06:48PM

Jul 29, 2017 07:12PM

Jul 30, 2017 08:49AM

Jul 30, 2017 12:44PM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith new VP

in response to

Re: Zenith new VP

Nextblockbuster

posted on Jul 31, 2017 12:31AM

Nbb - You could be onto something there with the excellent results with the current trial and it is now time to look further down the road to the other 1499 molecules to keep this Star Factory as SF calls it moving forward.

Does anyone know if the point person for this trial is still with Zenith? If not where did he go? and why?

tada

2 Recommendations

Re: Zenith new VP

SanFrancisco99

Jul 31, 2017 01:09AM

Re: Zenith new VP

tada

Jul 31, 2017 09:07AM

Re: Zenith new VP

SanFrancisco99

Jul 31, 2017 11:09AM